Premium
Symptomatic increase in intracranial pressure following pancreatic enzyme replacement therapy for cystic fibrosis
Author(s) -
Nasr Samya Z.,
Schaffert Denise
Publication year - 1995
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.1950190615
Subject(s) - medicine , cystic fibrosis , pancreatic enzymes , enzyme replacement therapy , pancreatic disease , intracranial pressure , surgery , gastroenterology , pancreas , disease
A newly diagnosed 5‐month‐old infant with cystic fibrosis (CF) developed signs and symptoms of increased intracranial pressure (ICP) within days of starting pancreatic enzyme replacement therapy. Symptoms promptly resolved on two occasions after stopping enzyme replacement. At 10 months of age, enzyme replacement was well tolerated. © 1995 Wiley‐Liss, Inc.